Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
Rev. Soc. Bras. Med. Trop
;
49(6): 774-776, Dec. 2016. graf
Article
in English
| LILACS
| ID: biblio-1041383
ABSTRACT
Abstract INTRODUCTION:
Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals. RESULTS The technique is described in detail sufficient to enable replication.CONCLUSIONS:
The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Organometallic Compounds
/
Leishmaniasis, Cutaneous
/
Meglumine
/
Antiprotozoal Agents
Limits:
Humans
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2016
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Fundação Oswaldo Cruz/BR
/
Secretaria Municipal de Saúde de Timóteo/BR
Similar
MEDLINE
...
LILACS
LIS